Development of 6-substituted indolylquinolinones as potent Chek1 kinase inhibitors
Shaei Huang(United States Military Academy), Elizabeth Mahan(United States Military Academy), Xianzhi Mao(United States Military Academy), Steve Stirdivant(United States Military Academy), James C.H. Hardwick(Leiden University Medical Center), Rob Lobell(United States Military Academy), Marc Abrams(Dicerna Pharmaceuticals (United States)), George D. Hartman(Joint BioEnergy Institute), Keith Rickert(United States Military Academy), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Joan Zugay Murphy(United States Military Academy), Justin T. Steen(United States Military Academy), Bob Drakas(United States Military Academy), Kelly Hamilton(United States Military Academy), Eileen S. Walsh(Janssen (Switzerland)), R. M. Garbaccio(United States Military Academy), Carolyn A. Buser(United States Military Academy), Constantine Kreatsoulas(United States Military Academy), Michael Reilly(United States Military Academy), Steve Beck(United States Military Academy), Sanjeev Munshi(United States Military Academy), Youwei Yan(United States Military Academy), Mari Ikuta(United States Military Academy), Lawrence Kuo(United States Military Academy), Vinod Sardana(United States Military Academy), Weikang Tao(Shanghai Medical Information Center), Mark E. Fraley(United States Military Academy)
Cited by 40
Related Papers
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
|Cancer Cell|2016|855
The importance of synthetic chemistry in the pharmaceutical industry
|Science|2019|650
Total Synthesis of Spirotryprostatin A, Leading to the Discovery of Some Biologically Promising Analogues
|Journal of the American Chemical Society|1999|463
Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
|Proceedings of the National Academy of Sciences|1996|409